ANDA 88335, held by Mylan. Thioridazine Hydrochloride.
As of Nov 15, 2026, ANDA 88335 (Thioridazine Hydrochloride), held by Mylan, was not approved, with 2 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Thioridazine Hydrochloride100MG ยท tablet;oral | Thioridazine Hydrochloride | Discontinued |
| Apr 16, 1984 | Supplement 3Manufacturing | Approved | None posted |
| Apr 16, 1984 | Supplement 4Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
